首页> 外国专利> Tetrahidropiridoazepin - 8 - onas as modulators of dopamine D2 receptor and related compounds for the treatment of Schizophrenia and other CNS disorders, Pharmaceutical compositions containing them and their use in the preparation of medicines.

Tetrahidropiridoazepin - 8 - onas as modulators of dopamine D2 receptor and related compounds for the treatment of Schizophrenia and other CNS disorders, Pharmaceutical compositions containing them and their use in the preparation of medicines.

机译:Tetrahidropiridoazepin-8-作为多巴胺D2受体和相关化合物的调节剂,用于治疗精神分裂症和其他CNS疾病,含有它们的药物组合物及其在制备药物中的用途。

摘要

Pharmaceutical ingredients containing these compounds and their use in the treatment of NCRE disorders and other disorders. Item 1: a formula compound (1) a salt acceptable from a drug, wherein G is a group of formulas selected from formula (2) or formula (3), where a is - (CH2) MH2 -.- (CH2) mO- o - (CH2) mNH-Where m is an integer from 3 to 5, in which two atoms of C - (CH2) MH2 are selectively linked by a double bond, and one or two atoms of C or N - (CH2) MH2,-(CH2) Mo-Y - (CH2) MNH - can be replaced by methyl or ethyl alone; D is n, C or CH, provided that when D is n, each atom from C to D is connected through a simple link; J and K are selected independent of N, CH and C; Q, y and Z are selected independent of N or C; The choice of V and W is independent of N, C or CH; AA ring is a saturated or unsaturated carbon cycle composed of 5, 6 or 7 members, in which one, two or three C atoms that are not shared with arilo cycles of 6 members (2) in AA ring can be replaced by N atoms arbitrarily and independently. That's it.R2 and R3 are independently selected from H, halo, cyano, hydroxy, C1-4 alkyl and C1-4 alkoxy, wherein the C1-4 alkyl or C1-4 alkoxy moieties are linear or branched and may be optionally substituted with one to three fluoro atoms and may also be optionally substituted with an amino or hydroxy substituent, provided that when Q is N, R1 is absent and when Y is N, R2 is absent; R4, R5, R6, R7, R8, and R9 are independently selected from H, fluoro, hydroxy, C1-4 alkyl and C1-4 alkoxy, wherein the C1-4 alkyl or C1-4 alkoxy moieties are linear or branched; provided that when it is N, R8 cannot be fluoro or hydroxyl,When Z is n, R9 is not present; R10 is an independent choice independent of H, C1-4 and alcoxi 1-4, in which case, C1-4 or alcoxi C1-4 asphalt macadam is linear or branched; R11, R12, R13, R14 and R15 are selected without considering h, halo, (= O) CH3, C1-4 asphalt and alcoxi-4, arilo and ariloxi, in which all debris contains asphalt. Among C1-4, C1-4 and C (= O) CH3 tar groups and arilo and ariloxi residues, one to three fluorine atoms can be used as alternatives, or aminobenzene or hydrogen Xi can be used as alternatives; R16 and R17 are independent of H, halo, Ciano, oxo, hidroxi - (= O) CH3.C1-4 and alcox C1-4, in which the residues of C1-4, C1-4 and - C (= O) CH3 tar group can be replaced by one to three fluorine atoms or one or more amino or hydroxyl substitutes.
机译:包含这些化合物的药物成分及其在治疗NCRE疾病和其他疾病中的用途。第1项:式化合物(1)为药物可接受的盐,其中G为选自式(2)或式(3)的一组式,其中a为-(CH2)MH2- -.-(CH2)mO -o-(CH 2)mNH-其中m是3至5的整数,其中C-(CH 2)MH 2的两个原子通过双键选择性地连接,并且C或N-(CH 2)的一个或两个原子MH2-(CH2)Mo-Y-(CH2)MNH-可以单独被甲基或乙基取代; D是n,C或CH,条件是当D为n时,从C到D的每个原子都通过一条简单的链连接。 J和K的选择独立于N,CH和C; Q,y和Z的选择独立于N或C; V和W的选择独立于N,C或CH; AA环是由5、6或7个成员组成的饱和或不饱和碳环,其中一个,两个或三个与AA环中的6个成员(2)的芳环不共享的C原子可以被N个原子任意取代并且独立。就是这样,R2和R3独立地选自H,卤素,氰基,羟基,C1-4烷基和C1-4烷氧基,其中C1-4烷基或C1-4烷氧基部分是直链或支链的,并且可以任选地被1-3个氟原子,并且还可以任选地被氨基或羟基取代基取代,条件是当Q为N时,不存在R1,而当Y为N时,不存在R2; R4,R5,R6,R7,R8和R9独立地选自H,氟,羟基,C1-4烷基和C1-4烷氧基,其中C1-4烷基或C1-4烷氧基部分是直链或支链的;前提是当它为N时,R8不能为氟或羟基;当Z为n时,R9不存在; R10是独立于H,C1-4和Alcoxi 1-4的独立选择,在这种情况下,C1-4或Alcoxi C1-4沥青碎石是直链或支链的;选择R11,R12,R13,R14和R15时不考虑h,卤素,(= O)CH3,C1-4沥青和alcoxi-4,arilo和ariloxi,其中所有碎屑均包含沥青。在C1-4,C1-4和C(= O)CH3焦油基团以及芳基和芳基残基中,可以使用1-3个氟原子作为替代,或者可以使用氨基苯或氢Xi作为替代。 R16和R17独立于H,卤素,Ciano,氧代,Hidroxi-(= O)CH3.C1-4和alcox C1-4,其中C1-4,C1-4和-C(= O)的残基CH 3焦油基团可以被1-3个氟原子或一个或多个氨基或羟基取代基取代。

著录项

  • 公开/公告号AR053835A1

    专利类型

  • 公开/公告日2007-05-23

    原文格式PDF

  • 申请/专利权人 WARNER-LAMBERT COMPANY LLC;

    申请/专利号AR2006P101253

  • 发明设计人

    申请日2006-03-30

  • 分类号

  • 国家 AR

  • 入库时间 2022-08-21 20:59:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号